Penn Medicine offers everything you need to know about acute lymphocytic leukemia, its symptoms, how it is managed, treatment options and groundbreaking clinical trials and research.
Acute lymphocytic leukemia (ALL) is a cancer of the blood in which immature cells called "blasts" overtake a person's bone marrow. ALL is the most common type of childhood cancer, but it is more common in adults.
Because ALL progresses rapidly, once a person is diagnosed with the disease, they must begin treatment as soon as possible.
ALL can be characterized into subtypes based on the presence of the Philadelphia chromosome, which was discovered at Penn Medicine. Knowing the type of ALL can help customize a treatment plan.
Acute lymphocytic leukemia can be treated at the Abramson Cancer Center by our Leukemia Program.
Every step of cancer treatment, from a cancer diagnosis and treatment, to forming a survivorship plan, comes with different needs and issues that should be addressed.
Oncology navigators are committed to making sure every patient experience is as comfortable as possible. They are experts in navigating complex health care situations and serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families.